Quelles sont les heures d'ouverture ?

Lundi 08:30 - 17:00 Mardi 08:30 - 17:00 Mercredi 08:30 - 17:00 Jeudi 08:30 - 17:00 Vendredi 08:30 - 17:00

European Cancer Organisation

Accueil
België
Bruxelles / Brussel
European Cancer Organisation

Itinéraire Site Web

Working together to build consensus and achieve improvement in cancer care.

The European Cancer Organisation

Our Mission

To reduce the burden of cancer, improve outcomes and the quality of care for cancer patients, through multidisciplinarity and multiprofessionalism. As the not-for-profit federation of member organisations working in cancer at a European level, we convene oncology professionals and patients to agree policy, advocate for positive change and be the united voice of the European cancer community. Our Vision

To be a vibrant, pro-active, focused, relevant and influential federation, working together for a cancer free future, ensuring that every patient has high quality care and treatment, with access to the full range of professionals needed. To create and develop ever-strengthening relationships between European institutions and the European cancer care community, and with our Member Societies and networks, facilitate collaboration and consensus on focused topics towards tangible and impactful policy improvement. Our Values

Our essential and enduring values are:

-Patient Centricity – Putting cancer patients at the centre of our concerns and activities and strive to do the best for them

- Commitment to Science – Reflecting the very latest scientific knowledge and be completely independent of any vested interests

- Cohesiveness – We believe in the power of combining the efforts of our members and other stakeholders who have a common mission

- Inclusiveness – We seek to include all non-profit organisations that share our mission, vision and values

- Equality and Fairness – All our members have a voice in the organisation and we strive to transcend the interests of any one member

- Openness and Transparency – We are committed to be transparent in and accountable for all that we do

09/10/2026

A strong step forward for more equitable, gender-sensitive cancer policy in Europe.

This new report, led by Billy Kelleher MEP and reflecting ECO’s policy priorities, include calls for:

🔹 More ambitious and equitable cancer screening
🔹 Gender-sensitive screening and vaccination programmes
🔹 Greater access to innovative diagnostics, including biomarker testing
🔹 An EU-wide Right to Be Forgotten
🔹 Stronger action on cancer prevention and health inequalities

Separately, ECO’s latest report ‘Women & Cancer: From Evidence to Action’ sets out recommendations for improving access to diagnostics and treatment and strengthening prevention and early detection.

🔗 Explore ECO’s work on Women & Cancer: https://europeancancer.org/womenandcancer

📄 Read Women & Cancer: From Evidence to Action: https://europeancancer.org/resources/publications/reports/women-cancer-from-evidence-to-action.html

Read the European Parliament report:https://www.europarl.europa.eu/RegData/seance_pleniere/textes_adoptes/definitif/2026/09-16/0305/P10_TA(2026)0305_EN.pdf

09/10/2026

Europe Losing Its Share of Cancer Trials 📉

In 2008, Europe's share of global oncology trials stood at 41%. By 2023, it had fallen to 21%.

A new report from the European Cancer Organisation (ECO) sounds the alarm. But this is not a story of decline. It's a story of opportunity. 💡

💬 ‘Europe has the science to lead the world in cancer care. What it has lacked is the strategy to match it. Put cancer innovation at the heart of Europe's competitiveness agenda and turn scientific excellence into better outcomes for cancer patients in every member state.’ - Isabel Rubio, President, European Cancer Organisation

To seize the lead, ECO sets out a clear roadmap:
✅ Put oncology innovation at the centre of Europe's competitiveness strategy
✅ Build on Europe's Beating Cancer Plan and the EU Cancer Mission
✅ Resolve regulatory barriers (GDPR interpretation, IVDR, the Clinical Trials Regulation)
✅ Reduce fragmentation so new treatments reach patients sooner

ECO urges the European Commission and EU member states to weigh these recommendations as they shape Europe’s new competitiveness agenda.

👉 Read the full report: https://www.europeancancer.org/resources/publications/seizing-the-moment

08/10/2026

Europe is home to world-class research and scientific expertise. Yet regulatory barriers, fragmented clinical research and unequal access can prevent new treatments from reaching patients.

On 12 October, the Expert Dialogue on the EU Biotech Act will bring policymakers and experts together to explore how Europe can:

🔹 Improve the environment for clinical research for cancer and rare diseases

🔹 Strengthen cross-border collaboration

🔹 Support biotechnology innovation and advanced therapies

🔹 Help new treatments reach patients more quickly and equitably

The dialogue is organised by the Secretariat of the European Parliament Intergroup on Cancer and Rare Diseases, comprising the European Cancer Organisation, EURORDIS-Rare Diseases Europe and SIOP Europe.

Find out more: https://www.intergrouponcancerandrarediseases.eu/events/expert-dialogue-on-eu-biotech-act

08/10/2026

On 13–14 October, the SANGUINE project comes to Brussels – and online – with a look at the future of blood cancer detection.

Join us live on YouTube and follow the showcase event from wherever you are.

Just keep in mind: This isn’t a ‘watch and scroll’ kind of livestream.

Online participants can ask questions in real time and be part of the exchange around the HemaChip, the SANGUINE project and what comes next for innovative blood cancer detection.

🎥 Want the livestream link? Register for the event and select ‘online participation’. Your YouTube link will be sent to you by email.

Registration is closing soon⏰ https://forms.cloud.microsoft/e/bXrjmcpY2U

07/10/2026

Over nearly three years, has brought professionals from across Europe together to learn across specialities and strengthen collaboration in cancer care.

Now we’ll meet in Brussels to share what we’ve learned and explore how this experience can help shape the future of inter-speciality cancer training.

📅 Friday 20 November 2026
📍 Brussels & Online

Discover the programme and request registration: https://www.europeancancer.org/events/441:isct-conference.html

06/10/2026

The stage is getting bigger… and the countdown is getting shorter. ⏳

The SANGUINE Showcase event is shaping up to be as groundbreaking as the technology:

Think interactive exhibition. Live HemaChip demonstrations. SANGUINE goodies. Fresh perspectives. And real opportunities to connect with the people driving innovation across cancer detection, biotech and cancer policy.

Our speaker line-up is also growing. Just take a look.

Whether you come for the science, the technology, the conversations (or all three), this is one event you’ll want to experience.

⏰ 13–14 October
📍 Brussels & online

Free registration here 🎟️ https://www.europeancancer.org/events/449:transforming-blood-cancer-detection-through-european-innovation

06/10/2026

Awareness is only the beginning.

Organised screening, timely diagnosis and high-quality care depend on health systems that can reach women, follow them through the pathway and deliver consistent standards of care.

In the first expert commentary of our Pink October 2026 series, Dr Isabel Rubio looks at what Europe can do to close the gap between the standards it has developed and the care women actually receive.

Read “Pink October – What We’re Missing”: https://www.europeancancer.org/campaign/impact/pink-october---what-were-missing.html

05/10/2026

🔬 The project brings together expertise from across Europe to investigate aerosolised chemotherapy as a new approach for treating cancers that have spread within the abdomen or around the lungs. 💨

But IMPACT goes beyond testing a treatment. It will combine clinical research with patient involvement, quality-of-life assessment, health economics and implementation research to understand not only whether the approach works, but how it could contribute to future cancer care. 👥📊

🤝 By connecting research, innovation and patient needs, IMPACT aims to generate evidence that can support better treatment decisions across Europe.

👉 Find out more about the project: https://eu-impact.org/

01/10/2026

Are you at the EU Cancer Mission fair in Brussels today?

Come to our booth and say hello to the team. Let’s talk about this ground-breaking project and how it’s supporting interdisciplinary cancer training across Europe.

We have a lot to share.

In the meantime, learn more here - https://www.europeancancer.org/eu-projects/impact/interact-europe-100

01/10/2026

October is . 🎗️

Across the WHO European Region, an estimated 9.7 million people live with hepatitis B and 5.6 million with hepatitis C, major preventable causes of liver disease and liver cancer. 👈

Together with our members and partners, we’re working to strengthen prevention, improve awareness and access to testing and treatment, and ensure the link between viral hepatitis and cancer is not overlooked.

This month, along with the European Liver Patients Association, the European Association for the Study of the Liver and the World Hepatitis Alliance, we’re calling for stronger action across Europe to prevent liver cancer before it develops. 💡

Adresse

Rue De La Science 41
Brussels
1040

Heures d'ouverture

Lundi	08:30 - 17:00
Mardi	08:30 - 17:00
Mercredi	08:30 - 17:00
Jeudi	08:30 - 17:00
Vendredi	08:30 - 17:00

Site Web

https://www.europeancancer.org/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque European Cancer Organisation publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.